Cancer Health Treatment Update Lorbrena Yields “Unprecedented” Progression-Free Survival for ALK-Positive Lung Cancer With five years of follow-up, first-line lorlatinib reduced the risk of disease progression or death as well as progression of brain metastasis. Cancer Health Summer 2024 Check out our latest print edition! New Study Finds Regular Exercise Program Impacts Cancer Risk Adhering to physical activity recommendations could significantly lower the risk of developing cancer. HPV Vaccine Prevents Cancer in Both Women and Men Vaccination was linked to lower rates of cervical cancer among young women and mouth and throat cancer among young men. News From ASCO 2024 See all our reports from the world's biggest cancer conference. American Cancer Society and ASCO Unite to Create Comprehensive Online Source of Credible Cancer Information The collaboration advances the Cancer Moonshot’s call to empower patients and reduce duplication of effort. Advertisement News About COVID-19 See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. Newsfeed NBA Star Alonzo Mourning Cancer-Free After Surgery to Remove Prostate Are Tattoos a Risk Factor for Lymphoma? CDC Confirms Second Human H5 Bird Flu Case in Michigan LGBTQ Cancer Report: Unique Stressors, Discrimination Likely Increase Cancer Risk Blog: National Cancer Institute Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses Inviting Innovation in Cancer Clinical Trials Ojemda Approved for Some Children With Brain Tumors Keytruda Provides First-Ever Overall Survival Improvement in Kidney Cancer Newsfeed NBA Star Alonzo Mourning Cancer-Free After Surgery to Remove Prostate Are Tattoos a Risk Factor for Lymphoma? CDC Confirms Second Human H5 Bird Flu Case in Michigan LGBTQ Cancer Report: Unique Stressors, Discrimination Likely Increase Cancer Risk Blog: National Cancer Institute Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses Inviting Innovation in Cancer Clinical Trials Ojemda Approved for Some Children With Brain Tumors Keytruda Provides First-Ever Overall Survival Improvement in Kidney Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: